Xeljanz 5 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB26FHGQS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,687
Award facts
- Contract value 100% obligated
- $2,686.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,686.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xeljanz 5 mg tablets (60-count units) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-competitive set-aside delivery order will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies critical medications and medical commodities to support Department of Defense medical needs. Xeljanz is a targeted immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the breadth of specialty pharmaceuticals the company provides through its DLA contract portfolio. The underlying IDC enables AmerisourceBergen to deliver diverse pharmaceutical products—including specialty medications, vaccines, and medical supplies across multiple therapeutic domains—to military healthcare systems globally, supporting the Defense Health Agency and other federal healthcare entities through a flexible contracting mechanism designed to ensure reliable supply chain support for military operations and personnel healthcare requirements.
Quick answers
Who was awarded contract SPE2DB26FHGQS?
SPE2DB26FHGQS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FHGQS worth?
The government has obligated $2,687 on SPE2DB26FHGQS.
Is contract SPE2DB26FHGQS an order under another contract?
Yes. SPE2DB26FHGQS is a delivery order under SPE2DB24D2208, an indefinite delivery contract.
Was contract SPE2DB26FHGQS competed?
The extent of competition for SPE2DB26FHGQS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award